Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 9 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 9856248

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted
  2. US 9840499

    Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

    Vertex Pharmaceuticals Incorporated · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted
  3. US 9828397

    Prodrugs of pyridone amides useful as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Nov 28, 2017 · Expires Nov 23, 2037

    granted
  4. US 9808459

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted
  5. US 9782408

    Modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  6. US 9783501

    Substituted quinolines as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted
  7. US 9776968

    Processes for producing cycloalkylcarboxamido-pyridine benzoic acids

    Vertex Pharmaceuticals Incorporated · Granted Oct 3, 2017 · Expires Sep 28, 2037

    granted
  8. US 9771361

    Inhibitors of influenza viruses replication

    Vertex Pharmaceuticals Incorporated · Granted Sep 26, 2017 · Expires Sep 21, 2037

    granted
  9. US 9758510

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  10. US 9758483

    Pyridone amides as modulators of sodium channels

    Vertex Pharmaceuticals Incorporated · Granted Sep 12, 2017 · Expires Sep 7, 2037

    granted
  11. US 9751890

    Heteroaryl derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  12. US 9751839

    Process for making modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Sep 5, 2017 · Expires Aug 31, 2037

    granted
  13. US 9732080

    Azaindole derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Aug 15, 2017 · Expires Aug 10, 2037

    granted
  14. US 9725440

    Modulators of CFTR

    Vertex Pharmaceuticals Incorporated · Granted Aug 8, 2017 · Expires Aug 3, 2037

    granted
  15. US 9718827

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Aug 1, 2017 · Expires Jul 27, 2037

    granted
  16. US 9701674

    Substituted pyrazines as ATR kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted
  17. US 9701639

    Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator

    Vertex Pharmaceuticals Incorporated · Granted Jul 11, 2017 · Expires Jul 6, 2037

    granted
  18. US 9676746

    Crystalline forms of C21H22Cl2N4O2

    Vertex Pharmaceuticals Incorporated · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  19. US 9676759

    Isoindolinone inhibitors of phosphatidylinositol 3-kinase

    Vertex Pharmaceuticals Incorporated · Granted Jun 13, 2017 · Expires Jun 8, 2037

    granted
  20. US 9670215

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  21. US 9670163

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 6, 2017 · Expires Jun 1, 2037

    granted
  22. US 9663519

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted May 30, 2017 · Expires May 25, 2037

    granted
  23. US 9650381

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted May 16, 2017 · Expires May 11, 2037

    granted
  24. US 9630956

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Apr 25, 2017 · Expires Apr 20, 2037

    granted